DNATRIX INC — Form D
DNATRIX INC of HOSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-25. The offering totals $41.2M, of which $15.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-09-25
- Form: D
- Accession: 0001446505-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $41.2M
- Amount sold: $15.5M
- Remaining: $25.7M
- Investors: 40
- Date of first sale: 2018-09-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-322084
Issuer
- Name: DNATRIX INC
- CIK: 0001446505
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: ONE GREENWAY PLAZA, SUITE 930, HOSTON, TX, 77046
- Phone: 713-715-6820
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Isaac Patrick Cheng | Director | Monaco, O9 |
| Francis Patrick McCormick | Director | San Francisco, CA |
| Drew Patrick Pardoll | Director | Baltimore, MD |
| Frank Tufaro | Director | Houston, TX |
| Daniel Watkins | Director | Houston, TX |
| Brian Patrick Mooney | Executive Officer | Houston, TX |
| Frank Tufaro | Executive Officer | Houston, TX |
| Daniel Watkins | Executive Officer | Houston, TX |
| Daniel M Watkins | Director | St. Louis, MO |
| Reenie Patrick McCarthy | Director | Monaco, O9 |
| Imre Patrick Kovesdi | Director | Rockville, MD |
| Imre Patrick Kovesdi | Executive Officer | Rockville, MD |
| Daniel M. Watkins | Director | Houston, TX |
| Daniel M. Watkins | Executive Officer | Houston, TX |
Other filings by this issuer (3)
More